Related Experiment Video

Updated: Aug 10, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Ursolic acid: an anti-tumorigenic and chemopreventive activity. Minireview

L Novotný1, A Vachálková, D Biggs

  • 1Faculty of Pharmacy, Health Science Center, Kuwait University, Safat. novotny@hsc.kuniv.edu.kw

Neoplasma
|November 20, 2001
PubMed

Insights

Ursolic acid (UA) exhibits significant anti-cancer properties by inducing tumor cell apoptosis and preventing normal cell transformation. This review highlights UA's potential as a chemopreventive agent against cancer.

Area of Science:

  • Oncology
  • Natural Products Chemistry
  • Molecular Biology

Background:

  • Ursolic acid (UA), a pentacyclic triterpene, possesses diverse biological activities relevant to cancer research.
  • UA demonstrates cytotoxicity, differentiation induction, and anti-mutagenic, antiviral, and anti-invasive effects.

Purpose of the Study:

  • To review the biological properties of Ursolic acid.
  • To summarize the anti-tumor effects of UA.
  • To elucidate the chemopreventive potential of UA in normal cells.

Main Methods:

  • Literature review of studies on Ursolic acid.
  • Analysis of reported biological activities and anti-cancer mechanisms.
  • Evaluation of UA's effects on tumor and normal cells.

Main Results:

  • Ursolic acid induces apoptosis in cancer cells.
  • UA prevents the malignant transformation of normal cells.
  • UA interferes with enzymes crucial for DNA synthesis.

Conclusions:

  • Ursolic acid exhibits dual action: tumor cell apoptosis induction and normal cell protection.
  • UA shows promise as a chemopreventive agent with broad anti-cancer applications.
  • Further research into UA's mechanisms and therapeutic potential is warranted.

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...